FDA Orange Book · active-ingredient family
Ceftazidime sodium
Ceftazidime sodium is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:FORTAZ IN PLASTIC CONTAINER · NDA 050634
1
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FORTAZ IN PLASTIC CONTAINERRLD×3 | PAI HOLDINGS PHARM | NDA 050634 | — | Apr 28, 1989 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CEFTAZIDIME SODIUM IN PLASTIC CONTAINER×3 | BAXTER HLTHCARE | ANDA 063221 | — | Apr 29, 1993 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ceftazidime sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
